NEW YORK, NY--(Marketwire - Mar 12, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotech company, could dramatically shift the stem cell conversation with its Cell-in-a-Box™ technology.

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & ...

Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited natural repair mechanisms. While stem cell therapy holds great promise for ...

Scientists are learning how to revive faltering human cells by loading them with fresh power plants, effectively repairing ...

Stem cells hold great promise for researching and treating neurodegenerative diseases. Like blank Scrabble tiles, they have the potential to become any cell in the body. Beyond the hype and danger of ...

Regenerative medicine offers a promising, accessible option for those seeking better mobility, reduced inflammation, stronger ...

Stem cells are characterized according to their degree of potency, which refers to their varying ability to differentiate into different cell types. Totipotent cells are the most potent of all stem ...

Several European biotechs, including Cellbox Labs, Evotec SE, Nanolive SA, and Salipro Biotech AB, have developed innovative ...

A combination of blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely prevented or cured type 1 diabetes in mice in a study by Stanford Medicine ...

When you were first conceived, you were a single cell. From this basic fact, we can extrapolate a few things, most especially that all the cells that make up your body today came (indirectly) from ...